about
Hepatitis C virus infection protein networkCancer-associated fibroblasts in hepatocellular carcinomaCommon Variants of the Prostaglandin-Endoperoxide Synthase 2 Gene and Hepatocellular Carcinoma SusceptibilityPrediction of fibrosis progression in chronic viral hepatitisHCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2Altered expression of cell cycle and apoptotic proteins in chronic hepatitis C virus infectionUnderlying Pathophysiology of HCV Infection in HIV-Positive Drug UsersGene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinomaInduction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis CCytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infectionKinetics of miR-122 expression in the liver during acute HCV infectionAn integrated transcriptomic and meta-analysis of hepatoma cells reveals factors that influence susceptibility to HCV infectionLiver fibrosisAPASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Inhibition of tyrosine kinase receptor Tie2 reverts HCV-induced hepatic stellate cell activationDiagnostic value of optimised real-time sonoelastography in the assessment of liver fibrosis in chronic hepatitis B and C.Global gene expression profiling of dimethylnitrosamine-induced liver fibrosis: from pathological and biochemical data to microarray analysis.Degradation of AIMP1/p43 induced by hepatitis C virus E2 leads to upregulation of TGF-β signaling and increase in surface expression of gp96.Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes.Liver cirrhosisHepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 inductionHIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaBActivation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells.SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C.MicroRNAs: Role in Hepatitis C Virus pathogenesisHepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In VivoEvaluation of the Chinese Medicinal Herb, Graptopetalum paraguayense, as a Therapeutic Treatment for Liver Damage in Rat Models.Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis.Functional signatures of protective antiviral T-cell immunity in human virus infections.A novel double antibody sandwich-lateral flow immunoassay for the rapid and simple detection of hepatitis C virusEffect of Antiviral Therapy on Serum Activity of Angiotensin Converting Enzyme in Patients with Chronic Hepatitis C.Hepatitis C virus infection, microRNA and liver disease progressionEffects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis.Hepatitis C Virus-Induced Monocyte Differentiation Into Polarized M2 Macrophages Promotes Stellate Cell Activation via TGF-βHepatic stellate cells, liver innate immunity, and hepatitis C virusMicrosomal Epoxide Hydrolase Polymorphisms and Haplotypes as Determinants of Hepatitis B Virusand Hepatitis C Virus-related Liver Disease in Indian PopulationMetabolomic investigations of human infections.Pathogenesis of liver cirrhosis.
P2860
Q24311906-228272CB-6D51-4442-B8DE-16EBAC1BDF57Q26738536-49296D0A-42A9-4A9D-8444-58BD9960B240Q26786180-489DB9A1-B9B4-4E35-954A-8F49CBBFB728Q26823671-D1BBA5CB-A328-496A-A0F5-C1EA4CA7198FQ27468911-8DADEC4C-AD29-429C-B80E-2B7ACB1BCA20Q27486649-BB7833EB-7E13-4841-90E3-CFB7A49A3F1BQ27489073-EEAF4230-A1FA-40C6-A5FC-6163F923C577Q27490242-B913EBAF-422E-4500-9B9F-9F28CD857C22Q27490352-37AF3699-0BFA-4641-BBF2-E9BE43572F1FQ28480545-CC1FD164-7533-4146-80EA-7105D063AE3DQ28534077-208D93FB-CB83-4AF4-BDED-12F63F9BD300Q28743482-1FC7B680-CD39-4F3F-A203-6CADBBADD92FQ29547449-0BAF6F47-67C5-4154-B33A-5AF1DD9C9920Q30250088-8704D42A-235B-40EB-89EA-1F3585D10E8CQ30303127-798B3C8B-4444-4C51-A103-6097DD848F44Q30360508-06017AA8-525F-4CB1-B9D9-DFE9537FFB9AQ33259183-0238E5F6-E654-48A3-BF1B-3302BD8CEBE2Q33590116-4A029F9A-31DD-4995-AF2C-7541C0389649Q33731308-94153FC9-A49D-4E1A-A695-19EF0642FD70Q33861095-4A20F4A1-3DFF-4509-B3F5-267882754B6CQ34010340-37623D5C-ECE7-422A-85C8-7A3E1641CAC1Q34023700-104B3563-9AE8-4731-9119-1A31F8B27D5DQ34509401-FB2370C6-2CC3-444E-8F22-A1AC260A4769Q34598615-71575881-9B50-4CAB-ADEA-6573FE567B4BQ35532301-B710EA70-A8FC-4AEE-9C4D-AC933BB09CB6Q35596308-6451322F-FA42-4BEB-8817-D11CEABBC4FEQ35606627-9BFD50CE-D9D2-4451-9645-AD206EE299FAQ35647851-F6E3BE5A-36E4-4FEF-8CF5-7C9895656060Q36090999-3DC3D26F-236A-4D30-9803-0EE65B1C3A9CQ36428322-1E21D572-1996-498A-B05B-CCE7D4CB89AEQ36529008-004E389A-B24D-4D04-B07D-694019AEF1F6Q36613617-25F2109D-3AF4-44E1-B2B7-0FDF3FBD6AF1Q36853076-09D81393-100A-41DC-96ED-216C38C7D7B4Q37196517-5497B463-BCE8-46D1-AB83-D2609D77C32CQ37269913-1BEE24CF-3BD1-436C-AB1A-7589634FC4C9Q37296716-52CDB7B2-581F-4E76-BCB8-3848B0A34D19Q37607847-D6F94843-A52A-4B18-97A1-89F3AD789265Q37613185-B6531EBD-058A-41DB-A9BB-FCED83FEC994Q38005436-69161479-CA28-48BD-8F69-E761ACDA9FE8Q38223369-1B75AD1C-23D7-405B-A74F-0FC89ED1F6C4
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hepatitis C and liver fibrosis.
@ast
Hepatitis C and liver fibrosis.
@en
type
label
Hepatitis C and liver fibrosis.
@ast
Hepatitis C and liver fibrosis.
@en
prefLabel
Hepatitis C and liver fibrosis.
@ast
Hepatitis C and liver fibrosis.
@en
P2093
P2860
P356
P1476
Hepatitis C and liver fibrosis.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.CDD.4401163
P478
10 Suppl 1
P577
2003-01-01T00:00:00Z